stockrowCastle Biosciences, Inc. (CSTL) vs Personalis, Inc. (PSNL)
- Castle Biosciences, Inc. CSTL 32.65 −4.53%
- Personalis, Inc. PSNL 15.81 +1.67%
Castle Biosciences, Inc. and Personalis, Inc. are both Diagnostics & Research companies. Personalis, Inc. is the larger, with a market value of $1.7B against $1.0B — 1.6× the size. Personalis, Inc. grew revenue faster over the last twelve months: 16.9% against 9.78%. Castle Biosciences, Inc. has the higher net margin (−6.10% vs −147.7%) and the higher return on invested capital (−3.63% vs −358.4%). Across the 18 metrics below, Castle Biosciences, Inc. leads on 14 and Personalis, Inc. on 4.
Valuation
Profitability
| Metric | CSTL | PSNL | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 77.07% | 16.71% | 48.32% |
| Operating margin | (7.43%) | (156.66%) | (5.68%) |
| Net margin | (6.10%) | (147.74%) | (4.10%) |
| Free cash flow margin | 1.06% | (120.79%) | 0.00% |
| Return on equity | (4.87%) | (62.14%) | 0.00% |
| Return on assets | (4.03%) | (44.66%) | (6.05%) |
| Return on invested capital | (3.63%) | (358.37%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack